article · World Journal of Virology
QTc prolongation without Tsd was observed at a lower frequency in patients treated with HCQ-AZI <i>vs</i> doubase C. The absence of comorbidities and concurrent use of other products that are likely to cause arrhythmia may explain our results.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.5501/wjv.v13.i2.90668
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
